- James W. SlaterAffiliated withCollege of Pharmacy, Oregon State University and Oregon Health Sciences University
- , Andrew D. ZechnichAffiliated withDepartment of Emergency Medicine, Oregon Health Sciences University
- , Dean G. HaxbyAffiliated withCollege of Pharmacy, Oregon State UniversityDepartment of Family Medicine, Oregon Health Sciences University Email author
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Second-generation histamine H1 receptor antagonists (antihistamines) have been developed to reduce or eliminate the sedation and anticholinergic adverse effects that occur with older H1 receptor antagonists. This article evaluates second-generation antihistamines, including acrivastine, astemizole, azelastine, cetirizine, ebastine, fexofenadine, ketotifen, loratadine, mizolastine and terfenadine, for significant features that affect choice.
In addition to their primary mechanism of antagonising histamine at the H1 receptor, these agents may act on other mediators of the allergic reaction. However, the clinical significance of activity beyond that mediated by histamine H1 receptor antagonism has yet to be demonstrated.
Most of the agents reviewed are metabolised by the liver to active metabolites that play a significant role in their effect. Conditions that result in accumulation of astemizole, ebastine and terfenadine may prolong the QT interval and result in torsade de pointes. The remaining agents reviewed do not appear to have this risk. For allergic rhinitis, all agents are effective and the choice should be based on other factors. For urticaria, cetirizine and mizolastine demonstrate superior suppression of wheal and flare at the dosages recommended by the manufacturer.
For atopic dermatitis, as adjunctive therapy to reduce pruritus, cetirizine, ketotifen and loratadine demonstrate efficacy. Although current evidence does not suggest a primary role for these agents in the management of asthma, it does support their use for asthmatic patients when there is coexisting allergic rhinitis, dermatitis or urticaria.
- Second-Generation Antihistamines
Volume 57, Issue 1 , pp 31-47
- Cover Date
- Print ISSN
- Online ISSN
- Springer International Publishing
- Additional Links
- Industry Sectors
- Author Affiliations
- 1. College of Pharmacy, Oregon State University and Oregon Health Sciences University, Portland, Oregon, USA
- 2. Department of Emergency Medicine, Oregon Health Sciences University, Portland, Oregon, USA
- 3. College of Pharmacy, Oregon State University, Portland, Oregon, USA
- 3. Department of Family Medicine, Oregon Health Sciences University, Portland, Oregon, USA